Pamela P. Palmer
2014
In 2014, Pamela P. Palmer earned a total compensation of $1.7M as Chief Medical Officer at AcelRx Pharmaceuticals, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $104,987 |
|---|---|
| Option Awards | $1,127,522 |
| Salary | $421,000 |
| Other | $7,800 |
| Total | $1,661,309 |
Palmer received $1.1M in option awards, accounting for 68% of the total pay in 2014.
Palmer also received $105K in non-equity incentive plan, $421K in salary and $7.8K in other compensation.
Rankings
In 2014, Pamela P. Palmer's compensation ranked 5,328th out of 13,032 executives tracked by ExecPay. In other words, Palmer earned more than 59.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,328 out of 13,032 | 59th |
Division Manufacturing | 1,906 out of 4,965 | 62nd |
Major group Chemicals And Allied Products | 639 out of 1,690 | 62nd |
Industry group Drugs | 490 out of 1,369 | 64th |
Industry Pharmaceutical Preparations | 383 out of 1,042 | 63rd |
Source: SEC filing on April 28, 2017.
Palmer's colleagues
We found five more compensation records of executives who worked with Pamela P. Palmer at AcelRx Pharmaceuticals in 2014.
2014
Timothy Morris
AcelRx Pharmaceuticals
Chief Financial Officer
2014
Richard King
AcelRx Pharmaceuticals
Chief Executive Officer
2014
Badri Dasu
AcelRx Pharmaceuticals
Chief Engineering Officer
2014
Lawrence Hamel
AcelRx Pharmaceuticals
Chief Development Officer
2014
James Welch
AcelRx Pharmaceuticals
Chief Financial Officer
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019